Prism Schneider, MD, PhD (she/her/hers)

Professor and Orthopaedic Trauma Surgeon
University of Calgary
Calgary, Alberta, Canada

Presentation(s):

• Breast Cancer: We Are at a Higher Risk, Let’s Talk About It

  Wednesday, October 23, 2024
  3:55 PM – 4:50 PM EDT

  Financial Disclosure N/A

• BSFF/ISFR Symposium III: Effects of Traumatic Brain Injury and Bone Healing in Polytrauma Patient

  Wednesday, October 23, 2024
  2:40 PM – 2:50 PM EDT

  Financial Disclosures: Amgen Scientific Advisory Board: Board or committee member|Canadian Journal of Surgery: Editorial or governing board|Johnson & Johnson: Research support|Orthopaedic Trauma Association: Board or committee member|Osteoporosis Canada: Board or committee member|Smith & Nephew: Research support|Stryker: Paid presenter or speaker|

• Hypercoagulability and Systemic Inflammation Contribute to Venous Thromboembolism in Orthopaedic Surgery Patients With Metastatic Bone Disease

  Wednesday, October 23, 2024
  3:34 PM – 3:38 PM EDT

  Financial Disclosures: Amgen Scientific Advisory Board: Board or committee member|Canadian Journal of Surgery: Editorial or governing board|Johnson & Johnson: Research support|Orthopaedic Trauma Association: Board or committee member|Osteoporosis Canada: Board or committee member|Smith & Nephew: Research support|Stryker: Paid presenter or speaker|

• Shock Volume Predicts Venous Thromboembolism Complications Following Orthopaedic Polytrauma

  Friday, October 25, 2024
  11:12 AM – 11:18 AM EDT

  Financial Disclosures: Amgen Scientific Advisory Board: Board or committee member|Canadian Journal of Surgery: Editorial or governing board|Johnson & Johnson: Research support|Orthopaedic Trauma Association: Board or committee member|Osteoporosis Canada: Board or committee member|Smith & Nephew: Research support|Stryker: Paid presenter or speaker|

• Shock Volume May Serve as an Early Predictor of Organ Dysfunction in Orthopaedic Polytrauma

  Friday, October 25, 2024
  11:18 AM – 11:24 AM EDT

  Financial Disclosure N/A

• Annual Meeting Symposium IV: Evidenced Based Management of the Orthopaedic Poly-Trauma Patient: A Canadian Orthopaedic Trauma Society (COTS) Perspective

  Saturday, October 26, 2024
  8:00 AM – 9:00 AM EDT

  Financial Disclosures: Amgen Scientific Advisory Board: Board or committee member|Canadian Journal of Surgery: Editorial or governing board|Johnson & Johnson: Research support|Orthopaedic Trauma Association: Board or committee member|Osteoporosis Canada: Board or committee member|Smith & Nephew: Research support|Stryker: Paid presenter or speaker|

• Thrombelastography R-Time Predicts Thromboembolism After Extremity Trauma: A Secondary Analysis of PREVENT CLOT

  Saturday, October 26, 2024
  10:27 AM – 10:33 AM EDT

  Financial Disclosure N/A

• Thromboelastography Can Identify Patients With Femur Fractures at Increased Risk for Venous Thromboembolism and Prolonged Platelet-Dominant Hypercoagulability

  Saturday, October 26, 2024
  11:36 AM – 11:42 AM EDT

  Financial Disclosures: Amgen Scientific Advisory Board: Board or committee member|Canadian Journal of Surgery: Editorial or governing board|Johnson & Johnson: Research support|Orthopaedic Trauma Association: Board or committee member|Osteoporosis Canada: Board or committee member|Smith & Nephew: Research support|Stryker: Paid presenter or speaker|